MolNFT v1 · #481989 · protein
AlphaFold monomer V2.0 prediction for protein tweety homolog 2 (Q9BSA4)
Q9BSA4: “AlphaFold monomer V2.0 prediction for protein tweety homolog 2 (Q9BSA4)”. 4 pockets (best druggability 0.79). MolNFT v1 #481989 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- Accession
- Q9BSA4
- Type
- protein
- Length
- 534 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0xC746AF6f646b588a47acE344208619CfEF12dD4b
- Molecule
- Protein tweety homolog 2
- UniProt
- Q9BSA4
- Pockets
- 4 · best druggability 0.79
Structure
1 distinct chain · 68% helix, 1% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Protein tweety homolog 2 | protein | 534 | 68% helix, 1% strand | Q9BSA4 |
Pockets
4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 705 | 0.79 | 0.83 | 53 | empty |
| 2 | 300 | 0.56 | 0.76 | 23 | empty |
| 3 | 142 | 0.44 | 0.75 | 21 | empty |
| 4 | 72 | 0.28 | 0.72 | 15 | empty |
Modifications
Observed in the structure: 3 disulfide (disulfide).
Compared structures
- 7P54 · Cryo-EM structure of human TTYH2 in gdn · an experimental structure of the same protein · chain A against A, TM-score 0.74
- 7P54 · Cryo-EM structure of human TTYH2 in GDN · an experimental structure of the same protein · chain A against A, TM-score 0.74
- 7P5M · Cryo-EM structure of human TTYH2 in lipid nanodiscs · an experimental structure of the same protein · chain A against A, TM-score 0.73
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9BSA4
- Elsewhere: UniProt Q9BSA4 · AlphaFold DB Q9BSA4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.